A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

Part of paid clinical trials in Tucson, Arizona.

Sponsor
Bristol-Myers Squibb
Study ID
NCT05005273
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Nivolumab — DRUG
    Specified dose on specified days
  • Ipilimumab — DRUG
    Specified dose on specified days
  • BMS-986207 — DRUG
    Specified dose on specified days
  • Placebo — OTHER
    Specified dose on specified days

Study Details

The purpose of this study is to determine the safety and efficacy of BMS-986207 in combination with nivolumab and ipilimumab as first-line treatment for participants with stage IV non-small cell lung cancer (NSCLC).

Key Dates

Start date
Oct 3, 2022
Status verified
Jan 2024
Primary completion
Dec 27, 2022
Completion
Dec 27, 2022

Study Design

Enrollment
1 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A
  • Experimental: Arm B

Primary Outcome Measure

Progression Free Survival by BICR [ Time Frame: From first dose to progression or death, 2.3 months ]

Locations (17)

FacilityCityStateZIPSite coordinators
Local Institution - 0080TucsonArizona85719-
Local Institution - 0051Fountain ValleyCalifornia92708-
Local Institution - 0070Fort MyersFlorida33901-
Local Institution - 0073GainesvilleFlorida32610-
Local Institution - 0036Orange CityFlorida32763-
Local Institution - 0045PensacolaFlorida32504-
Local InstitutionPort Saint LucieFlorida34952-
Local Institution - 0068St. PetersburgFlorida33705-
Local InstitutionTallahasseeFlorida32308-
Local InstitutionWest Palm BeachFlorida33401-
Local Institution - 0081BoiseIdaho83706-
Local Institution - 0077Coeur d'AleneIdaho83214-
Local Institution - 0074EdgewoodKentucky41017-
Local Institution - 0002Ann ArborMichigan48109-
Local Institution - 0049BrooklynNew York11220-
Local Institution - 0012CharlestonSouth Carolina29414-
Local Institution - 0053MilwaukeeWisconsin53226-

Find similar trials in Tucson, AZ

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Local Institution - 0080· Tucson, AZLocal Institution - 0051· Fountain Valley, CALocal Institution - 0070· Fort Myers, FLLocal Institution - 0073· Gainesville, FLLocal Institution - 0036· Orange City, FLLocal Institution - 0045· Pensacola, FL

Related Studies